Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.
Zaky W, Dhall G, Ji L, Haley K, Allen J, Atlas M, Bertolone S, Cornelius A, Gardner S, Patel R, Pradhan K, Shen V, Thompson S, Torkildson J, Sposto R, Finlay JL. Zaky W, et al. Among authors: atlas m. Pediatr Blood Cancer. 2014 Jan;61(1):95-101. doi: 10.1002/pbc.24648. Epub 2013 Aug 11. Pediatr Blood Cancer. 2014. PMID: 23934933 Clinical Trial.
Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
Fangusaro JR, Jubran RF, Allen J, Gardner S, Dunkel IJ, Rosenblum M, Atlas MP, Gonzalez-Gomez I, Miller D, Finlay JL. Fangusaro JR, et al. Among authors: atlas mp. Pediatr Blood Cancer. 2008 Mar;50(3):715-7. doi: 10.1002/pbc.21032. Pediatr Blood Cancer. 2008. PMID: 17009232 Clinical Trial.
Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial.
Dhall G, O'Neil SH, Ji L, Haley K, Whitaker AM, Nelson MD, Gilles F, Gardner SL, Allen JC, Cornelius AS, Pradhan K, Garvin JH, Olshefski RS, Hukin J, Comito M, Goldman S, Atlas MP, Walter AW, Sands S, Sposto R, Finlay JL. Dhall G, et al. Among authors: atlas mp. Neuro Oncol. 2020 Dec 18;22(12):1862-1872. doi: 10.1093/neuonc/noaa102. Neuro Oncol. 2020. PMID: 32304218 Free PMC article. Clinical Trial.
Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial.
Venkatramani R, Ji L, Lasky J, Haley K, Judkins A, Zhou S, Sposto R, Olshefski R, Garvin J, Tekautz T, Kennedy G, Rassekh SR, Moore T, Gardner S, Allen J, Shore R, Moertel C, Atlas M, Dhall G, Finlay J. Venkatramani R, et al. Among authors: atlas m. J Neurooncol. 2013 Jun;113(2):285-91. doi: 10.1007/s11060-013-1111-9. Epub 2013 Mar 19. J Neurooncol. 2013. PMID: 23508296 Free PMC article.
Humanism and professionalism education for pediatric hematology-oncology fellows: A model for pediatric subspecialty training.
Kesselheim JC, Atlas M, Adams D, Aygun B, Barfield R, Eisenman K, Fulbright J, Garvey K, Kersun L, Nageswara Rao A, Reilly A, Sharma M, Shereck E, Wang M, Watt T, Leavey P. Kesselheim JC, et al. Among authors: atlas m. Pediatr Blood Cancer. 2015 Feb;62(2):335-340. doi: 10.1002/pbc.25253. Epub 2014 Oct 12. Pediatr Blood Cancer. 2015. PMID: 25307425
Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution.
Lakshminarayanan S, Sahdev I, Goyal M, Vlachos A, Atlas M, Lipton JM. Lakshminarayanan S, et al. Among authors: atlas m. Pediatr Transplant. 2010 Aug;14(5):618-21. doi: 10.1111/j.1399-3046.2009.01285.x. Epub 2009 Dec 30. Pediatr Transplant. 2010. PMID: 20051023
220 results